Literature DB >> 19869520

ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.

R C Lancefield1, E W Todd.   

Abstract

The matt and the glossy forms of four strains of hemolytic streptococci were used to immunize rabbits. Precipitin tests showed that rabbit sera prepared against matt organisms, whether virulent or avirulent for mice, contained type-specific antibody while sera prepared against completely degraded glossy organisms contained no type-specific antibody. Type-specific antibody was removed from the sera by absorption with homologous matt organisms but was unaffected by absorption with homologous glossy organisms. Passive protection experiments on mice showed that anti-matt sera were protective and anti-glossy sera non-protective against infection with homologous virulent organisms. Vaccination of mice with matt organisms rendered them immune to subsequent infection with homologous virulent cultures; but vaccination with glossy organisms established no active immunity.

Entities:  

Year:  1928        PMID: 19869520      PMCID: PMC2131507          DOI: 10.1084/jem.48.6.769

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  A STUDY OF HEMOLYTIC STREPTOCOCCI IN ACUTE RHEUMATIC FEVER, WITH AN ANALYSIS OF THE ANTIGENIC RELATIONSHIPS EXISTING AMONG CERTAIN STRAINS.

Authors:  C H Andrewes; C L Derick; H F Swift
Journal:  J Exp Med       Date:  1926-01-01       Impact factor: 14.307

2.  VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN.

Authors:  E W Todd; R C Lancefield
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

  2 in total
  22 in total

1.  [Virulence of A-Streptococci during various phases of growth].

Authors:  E VON WASIELEWSKI; E HERMANN
Journal:  Z Hyg Infektionskr       Date:  1957

2.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Group A Streptococcal Virulence: New Lessons.

Authors:  Stanford T Shulman; James B Dale
Journal:  J Pediatric Infect Dis Soc       Date:  2019-05-11       Impact factor: 3.164

Review 4.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

5.  Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus.

Authors:  Jason N Cole; Ruben D Ramirez; Bart J Currie; Stuart J Cordwell; Steven P Djordjevic; Mark J Walker
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus.

Authors:  R C LANCEFIELD; G E PERLMANN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

7.  The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci.

Authors:  A T WILSON
Journal:  J Exp Med       Date:  1959-03-01       Impact factor: 14.307

8.  STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : I. EFFECTS OF PROTEOLYTIC ENZYMES ON STREPTOCOCCAL CELLS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1943-12-01       Impact factor: 14.307

9.  STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : I. OBSERVATIONS ON THE VIRULENT, ATTENUATED, AND AVIRULENT VARIANTS.

Authors:  H K Ward; C Lyons
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

10.  The occurrence of two M antigens in certain group A streptococci related to type 14.

Authors:  G G WILEY; A T WILSON
Journal:  J Exp Med       Date:  1961-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.